Related to R&D Direction in 2012 for Sequencing Technologies Is Aimed at Clinical Medicine

• Biological Nanopore Sequencing Platform Reads DNA at Single-Nucleotide Resolution
  
• Roche Ups Bid for Illumina to $51 Per Share, or $6.5B
  
• Asuragen to Receive $6.8M from the Cancer Prevention and Research Institute of Texas
  
• Ingenuity, Life Tech Introduce Solution for Real-Time PCR Gene-Expression Analysis
  
• Illumina Shuns Roche’s Improved Acquisition Offer of $6.5B
  
• New York Genome Center Gets $3M from Sloan Foundation
  
• GE Snags Sequencing Services Firm SeqWright
  
• Life Technologies Pledges $20M to Expand Cell Culture Capacity at Scottish Site
  
• OncoMed Taps Genomic Health to Identify Predictive Biomarkers for Anticancer Antibodies
  
• Oxford Nanopore to Pocket £31.4M to Advance Single-Molecule Detection Technology
  
• Macrogen Taps into PerkinElmer’s Sample Prep Solutions for Next-Gen Sequencing
  
• 454, SoftGenetics Enter Co-Promotion Deal in Next-Gen Sequencing Informatics
  
• Evotec Becomes First European CRO to Offer Agilent’s RapidFire Screening Tool
  
• Agilent Acquires Cancer In Vitro Diagnostic Firm Dako for $2.2B in Cash
  
• Sequencing Study Suggests How VRSA Evolves Independently in Each Patient
  
• Life Technologies, OpGen to Develop Tools for Microbial Analysis, Outbreak Management
  
• Life Technologies, CDI to Commercialize Stem Cell Technologies
  
• Life Technologies Gains Rights to iPS Academia Japan’s Patents
  
• Qiagen Acquires Intelligent Bio-Systems with Aim to Advance Next-Gen Sequencing
  
• Eradicating Errors in Third-Gen Sequencing for de Novo Genome Assembly